mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
Asıl Yazarlar: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Nature Portfolio
2022-08-01
|
Seri Bilgileri: | npj Vaccines |
Online Erişim: | https://doi.org/10.1038/s41541-022-00511-y |
Benzer Materyaller
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
Yazar:: Susanne Rauch, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
Yazar:: Nicole Roth, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
Yazar:: Charlie Fricke, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
Yazar:: Nicole Roth, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Yazar:: Björn Corleis, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)